InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: FI101 post# 35385

Wednesday, 06/30/2021 9:34:17 AM

Wednesday, June 30, 2021 9:34:17 AM

Post# of 35961
From and interview with Alan Dukes 4/2015..

Some additional info on Dr Dionne and his confidence in Mipsagargin and his ability to transform cancer treatment.


This new drug treatment acts like a grenade because its toxic chemical is released from its wrapping only when it makes contact with a specific molecule in the blood vessels feeding tumors. Results from Phase II of this new drug treatment are showing promising results, GenSpera (www.genspera.com) is planning phase three testing for 2016, which could put mipsagargin on track for FDA approval for widespread use in 2018. "Cancer can't escape OUR drug. There is no way to get around it," Dionne says.

Dr. Craig Dionne is well on his way to be becoming the Steve Jobs of the bio tech world. In Alan Dukes new interview with Dr. Dionne he compares his accomplishments in cancer research, passion for finding a cure, and his creative innovative approach on par with other technological innovators –including Elon Musk, Jeff Bezos and Larry Page.

Many have listened to Dr Dionne only to be still waiting on mipsagargin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News